Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-08-002206
Filing Date
2008-04-01
Accepted
2008-03-31 21:51:00
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 MOLECULAR INSIGHT PHARMACEUTICALS, INC. b68183mie10vk.htm 10-K 1236585
2 EX-21.1 SUBSIDIARIES OF THE REGISTRANT b68183miexv21w1.htm EX-21.1 885
3 EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP b68183miexv23w1.htm EX-23.1 1605
4 EX-31.1 SECTION 302 CERTIFICATION OF CEO b68183miexv31w1.htm EX-31.1 9212
5 EX-31.2 SECTION 302 CERTIFICATION OF CFO b68183miexv31w2.htm EX-31.2 9293
6 EX-32.1 SECTION 906 CERTIFICATION OF CEO b68183miexv32w1.htm EX-32.1 4353
7 EX-32.2 SECTION 906 CERTIFICATION OF CFO b68183miexv32w2.htm EX-32.2 4309
8 GRAPHIC b68183mib6818301.gif GRAPHIC 9102
  Complete submission text file 0000950135-08-002206.txt   1280335
Mailing Address 160 SECOND STREET CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE MA 02142 617-492-5554
Molecular Insight Pharmaceuticals, Inc. (Filer) CIK: 0001340752 (see all company filings)

EIN.: 043412465 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33284 | Film No.: 08727145
SIC: 2834 Pharmaceutical Preparations